Headlands Technologies LLC Agios Pharmaceuticals, Inc. Transaction History

Headlands Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$24.53 - $35.75 $47,318 - $68,961	1,929 Added 18.0%	12,644 $420,000
Q1 2025 May 09, 2025	SELL	$29.3 - $35.9 $469,415 - $575,153	-16,021 Reduced 59.92%	10,715 $313,000
Q4 2024 Feb 12, 2025	BUY	$32.86 - $61.64 $426,818 - $800,641	12,989 Added 94.49%	26,736 $878,000
Q3 2024 Nov 12, 2024	BUY	$41.19 - $49.72 $94,613 - $114,206	2,297 Added 20.06%	13,747 $610,000
Q2 2024 Aug 07, 2024	BUY	$27.55 - $48.83 $315,447 - $559,103	11,450 New	11,450 $493,000

Q4 2023 Feb 02, 2024	SELL	$19.97 - $24.53 $2,875 - $3,532	-144 Reduced 1.59%	8,893 $198,000
Q3 2023 Nov 09, 2023	BUY	$24.36 - $28.18 $52,447 - $60,671	2,153 Added 31.28%	9,037 $223,000
Q2 2023 Aug 03, 2023	BUY	$21.38 - $29.19 $147,179 - $200,943	6,884 New	6,884 $194,000

256

63.8M

2.06M

911K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.39B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.